Loading organizations...
Loading organizations...

Hong Kong Asia Heart Centre: Cardiovascular specialist providing heart disease assessments and surgical services for patients.
Hong Kong Asia Heart Centre operates as a dedicated cardiovascular specialist chain, providing comprehensive heart disease assessments and surgical services across its facilities in Hong Kong. The organization maintains a professional medical team, experienced in the diagnosis and treatment of various complex cardiac conditions, including coronary artery disease, arrhythmias, and structural heart defects, utilizing advanced medical technologies. While specific operational metrics such as annual patient throughput, financial performance, or employee headcount are not publicly disclosed, the center emphasizes advanced cardiac care and specialized interventions. It caters to a broad patient demographic requiring specialized cardiology and cardiac surgery, focusing on delivering high-quality medical outcomes and post-operative support. The center has not publicly identified any lead investors, significant partners, or prominent customers. Hong Kong Asia Heart Centre was established in 1999; its founder names remain undisclosed.
Hong Kong Asia Heart Centre has raised $400.0M across 1 funding round.
Hong Kong Asia Heart Centre has raised $400.0M in total across 1 funding round.
Hong Kong Asia Heart Centre has raised $400.0M in total across 1 funding round.
Hong Kong Asia Heart Centre's investors include Country Garden Venture Capital, Jiaqi Zheng, General Atlantic, Hudson Bay Capital, ICBC International, Legend Capital, Sherpa Healthcare Partners, Taikang.
Hong Kong Asia Heart Centre has raised $400.0M across 1 funding round. Most recently, it raised $400.0M Series D in February 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 10, 2022 | $400.0M Series D | Country Garden Venture Capital, Jiaqi Zheng | General Atlantic, Hudson Bay Capital, ICBC International, Legend Capital, Sherpa Healthcare Partners, Taikang |